Private Advisor Group’s Virtus Biotech ETF BBP Stock Holding History

Private Advisor Group’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,200	Closed	-$104K	–	1738
2020 Q2	$104K	Buy	+2,200	New	+$98.3K	﹤0.01%	1682
2019 Q1	–	Sell	-6,025	Closed	-$210K	–	1544
2018 Q4	$210K	Buy	+6,025	New	+$229K	0.01%	1184
2018 Q2	–	Sell	-6,970	Closed	-$288K	–	1306
2018 Q1	$288K	Buy	+6,970	New	+$294K	0.01%	903
2017 Q4	–	Sell	-9,440	Closed	-$398K	–	1195
2017 Q3	$398K	Sell	9,440 -1,000	-10%	-$40K	0.01%	995
2017 Q2	$415K	Buy	+10,440	New	+$390K	0.01%	919

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SMG

Smart Money Group Eastland, Texas $344M AUM 16.66% 1-Year Est. Return

FAIM

Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Private Advisor Group's BBP Position: Q3 2020 in Review

Private Advisor Group sold out of Virtus Biotech ETF (BBP) in Q3 2020, closing a stake of 2,200 shares — an estimated $104K sold.

Private Advisor Group first reported a position in BBP in Q2 2017 and held it in 5 quarters. The position peaked at $415K in Q2 2017. 14 funds tracked by Wall St. Rank hold BBP as of Q3 2020.

Private Advisor Group reported no remaining Virtus Biotech ETF position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 2,200 Virtus Biotech ETF shares in Q3 2020, an estimated $104K.
Private Advisor Group first reported a position in Virtus Biotech ETF in Q2 2017 and held it in 5 quarters.
Private Advisor Group's Virtus Biotech ETF position peaked at $415K in Q2 2017.
14 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.